Rada; Vanessa L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rada; Vanessa L..The latest application filed is for "3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor".

Company Profile

3.9.12

Rada; Vanessa L. - Hatfield PA
Rada; Vanessa L. - West Point PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors Grant 11,332,463 - Crowley , et al. May 17, 2	2022-05-17
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210395224 - Acton, III; John J. ; et al.	2021-12-23
Substituted 6-membered Aryl Or Heteroaryl Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20210196734 - Crowley; Brendan M. ; et al.	2021-07-01
Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors Grant 11,026,958 - Crowley , et al. June 8, 2	2021-06-08
Substituted 6-membered Aryl Or Heteroaryl Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20210077511 - CROWLEY; BRENDAN M. ; et al.	2021-03-18
Spiropiperidine Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20210070745 - Crowley; Brendan M. ; et al.	2021-03-11
Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors Grant 10,870,630 - Crowley , et al. December 22, 2	2020-12-22
Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20190337910 - CROWLEY; BRENDAN M. ; et al.	2019-11-07
Substituted Bicyclic Heteroaryl Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20190308945 - CROWLEY; BRENDAN M. ; et al.	2019-10-10
Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use Grant 10,239,849 - Rudd , et al.	2019-03-26
Cyanopyridine Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their Use App 20180327374 - Rudd; Michael T. ; et al.	2018-11-15
Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20180030007 - Crowley; Brendan M. ; et al.	2018-02-01
Allosteric modulators of nicotinic acetylcholine receptors Grant 9,840,481 - Crowley , et al. December 12, 2	2017-12-12
Pyrimidone carboxamide compounds as PDE2 inhibitors Grant 9,815,796 - Shen , et al. November 14, 2	2017-11-14
Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20170275260 - CROWLEY; BRENDAN M. ; et al.	2017-09-28
Pyrimidone Carboxamide Compounds As Pde2 Inhibitors App 20170015633 - Shen; Dong Ming ; et al.	2017-01-19
Leucine-rich repeat kinase enzyme activity Grant 9,233,977 - McCauley , et al. January 12, 2	2016-01-12
Leucine-rich Repeat Kinase Enzyme Activity App 20130296317 - McCauley; John A. ; et al.	2013-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.